体外膜氧合作为危重患者挽救性技术的生存结局:宾夕法尼亚州2007-2015年结果
该研究为回顾性行政出院数据分析,纳入宾夕法尼亚州2007年至2015年所有2948例连续成人ECMO住院患者,按收治诊断分为呼吸、心脏、心脏骤停或未分类。9年间平均观察死亡率为51.7%;存活者中14.6%回家自我照护、15.2%接受家庭健康照护。全部存活者1个月内再入院率43.8%、1年内60.6%;老年存活者分别为52.3%和65.5%。院内死亡可能性随年龄增加而升高,出院回家或转至急性后期照护的可能性随年龄增加而降低。作者认为在「常规临床实践」背景下短期结局与 Conventional Ventilation or ECMO for Severe Adult Respiratory Failure 等临床试验、体外生命支持组织等登记处及较小单中心研究相似,需更多长期随访数据以帮助临床医生更好地告知患者选择与照护。
要点
- 宾夕法尼亚州2007-2015年2948例成人ECMO住院患者平均观察院内死亡率为51.7%。
- 全部存活者中14.6%回家自我照护,15.2%接受家庭健康照护。
- 全部存活者1个月内再入院率43.8%、1年内60.6%;老年存活者分别为52.3%和65.5%。
- 院内死亡可能性随年龄增加而升高,出院回家或转至急性后期照护的可能性随年龄增加而降低。
- 作者认为需更多长期随访数据以帮助临床医生更好地告知患者选择与照护。
适用人群与场景
- 宾夕法尼亚州2007年初至2015年底所有按 Diagnosis-Related Grouper 3 grouper 计费且存在体外膜氧合操作编码的2948例连续成人ECMO住院患者。
- 收治诊断按行政数据编码为呼吸、心脏、心脏骤停或未分类。
研究设计与关键结果
- 研究类型为行政出院数据的回顾性分析,数据来源为宾夕法尼亚州2007年至2015年全州行政出院数据,样本量2948例连续成人ECMO住院患者。
- 9年期间平均观察死亡率为51.7%。
- 全部存活者中14.6%回家自我照护,15.2%接受家庭健康照护。
- 全部存活者1个月内再入院率43.8%,1年内再入院率60.6%。
- 老年存活者1个月内再入院率52.3%,1年内再入院率65.5%。
- 院内死亡可能性随年龄增加而升高,出院回家或转至急性后期照护的可能性随年龄增加而降低。
- 作者结论认为在「常规临床实践」背景下短期结局与 Conventional Ventilation or ECMO for Severe Adult Respiratory Failure 等临床试验、体外生命支持组织等登记处及较小单中心研究相似。
证据类型、等级与局限
- 证据类型:行政出院数据的回顾性分析。
- 局限:作者指出需要更多长期随访数据,以便临床医生更好地告知患者选择与照护。
对床旁实践的改变
- 作者认为需更多长期随访数据以帮助临床医生更好地告知患者选择与照护。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To examine real-world outcomes of survival, length of stay, and discharge destination, among all adult extracorporeal membrane oxygenation admissions in one state over nearly a decade.
DESIGN: Retrospective analysis of administrative discharge data.
SETTING: State-wide administrative discharge data from Pennsylvania between 2007 and 2015.
PATIENTS: All 2,948 consecutive patients billed under a Diagnosis-Related Grouper 3 grouper and in whom a procedural code for extracorporeal membrane oxygenation was present, admitted between the beginning of 2007 and the end of 2015 to hospitals regulated by the state of Pennsylvania. Admitting diagnoses were coded as respiratory, cardiac, cardiac arrest, or uncategorized based on administrative data.
MEASUREMENTS AND MAIN RESULTS: Unadjusted in-hospital mortality, length of stay, and discharge destination. Summary statistics and tests of differences by age 65 years or older and by admitting diagnosis were performed. Outcomes by age were plotted using running-mean smoothed graphs. Over the 9-year period, the average observed death rate was 51.7%. Among all survivors, 14.6% went home to self-care and a further 15.2% to home health care. Of all survivors, 43.8% were readmitted within 1 month, and 60.6% within 1 year. Among elderly survivors, readmission rates were 52.3% and 65.5% within 1 month and 1 year, respectively. The likelihood of dying in-hospital increased with age that of being discharged home or to postacute care decreased.
CONCLUSIONS: In a "usual clinical practice" setting, short-term outcomes are similar to those observed in clinical trials such as Conventional Ventilation or ECMO for Severe Adult Respiratory Failure, in registries such as extracorporeal life support organization, and in smaller single-site studies. More data on longer term follow-up are needed to allow clinicians to better inform patient selection and care.
参考来源
- Huesch MD, Foy A, Brehm C, et al. Survival Outcomes Following the Use of Extracorporeal Membrane Oxygenation as a Rescue Technology in Critically Ill Patients: Results From Pennsylvania 2007-2015. Crit Care Med. 2018. PMID: 29112078. doi:10.1097/CCM.0000000000002801
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。